The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts
Veerle van Gils(Maastricht University), Stephanie J. B. Vos(Maastricht University), Argonde C. van Harten(Amsterdam Neuroscience), Daniel Damian(University Hospital of Lausanne), Johannes Streffer(University of Antwerp), Giuseppe Fanelli(Radboud University Nijmegen), Julius Popp(University of Lausanne), Pieter Jelle Visser(Karolinska Institutet), Wiesje M. van der Flier(Amsterdam Neuroscience), Magda Tsolaki(Aristotle University of Thessaloniki), Sebastiaan Engelborghs(Vrije Universiteit Brussel), Susana Jiménez‐Múrcia(Bellvitge University Hospital), Pablo Martínez‐Lage(Fundacion CITA Alzheimer), Anouk den Braber(Max Planck Institute for Psycholinguistics), Lutz Froelich(Heidelberg University), Barbara Franke(Radboud University Nijmegen), Inez H.G.B. Ramakers(Maastricht University), Nienke Legdeur(Amsterdam Neuroscience), Rik Vandenberghe(Allen Institute for Brain Science), Justine Moonen(Amsterdam Neuroscience), Charlotte E. Teunissen(Amsterdam Neuroscience), Kateřina Veverová(Charles University), Willemijn J. Jansen(Maastricht University), Jakub Hort(Charles University), Mònica Bulló(Institut de Recerca Biomèdica Catalunya Sud), Janita Bralten(Radboud University Nijmegen), Olivier Rouaud(University Hospital of Lausanne), Geert Poelmans(Radboud Institute for Molecular Life Sciences), Yvonne Freund‐Levi(Karolinska Institutet), Anders Wallin(University of Gothenburg), Markku Laakso(University of Eastern Finland), Simon Lovestone(Johnson & Johnson (United Kingdom)), Henrik Zetterberg(University of Wisconsin System), Anette Hall(University of Eastern Finland), Alberto Lleó(Universitat Autònoma de Barcelona), Jordi Salas‐Salvadó(Instituto de Salud Carlos III), Fernando Fernandez‐Arande(Instituto de Salud Carlos III), Søren Dalsgaard(Lundbeck Foundation)
Cited by 0
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
|Nature Genetics|2018|2.3k
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k